COMMUNIQUÉS West-GlobeNewswire

INNATE PHARMA REÇOIT LE STATUT « FAST TRACK » DE LA FOOD AND DRUG ADMINISTRATION (FDA) POUR IPH4102 CHEZ LES PATIENTS PRÉSENTANT UN SYNDROME DE SÉZARY EN RECHUTE OU RÉFRACTAIRE
29/01/2019
INNATE PHARMA REÇOIT LE STATUT « FAST TRACK » DE LA FOOD AND DRUG ADMINISTRATION (FDA) POUR IPH4102 CHEZ LES PATIENTS PRÉSENTANT UN SYNDROME DE SÉZARY EN RECHUTE OU RÉFRACTAIRE Le statut « Fast Track » vise à accélérer [...]
Cancer Genetics, Inc. Announces Pricing of $3.5 Million Public Offering of Common Stock
29/01/2019
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Kiniksa Pharmaceuticals, Ltd. Announces Proposed Public Offering and Concurrent Private Placement
28/01/2019
HAMILTON, Bermuda, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa,” “we,” and “our”) announced today that it is commencing a public offering of 8,000,000 Class A common shares. [...]
IMV to Present at 2019 BIO CEO & Investor Conference
28/01/2019
DARTMOUTH, Nova Scotia, Jan. 28, 2019 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, today announced that it will participate in the BIO CEO and Investor Conference [...]
Akorn Announces New Executive and Board Appointments
28/01/2019
LAKE FOREST, Ill., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), today announced that it has appointed a new executive team member and two new board members. Christopher C. Young joins Akorn as Executive [...]
Myriad to Announce Fiscal Second-Quarter 2019 Financial Results on February 5, 2019
28/01/2019
SALT LAKE CITY, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will hold its fiscal second-quarter 2019 sales [...]
Corvus Pharmaceuticals Announces Appointment of New Member of Board of Directors and Hiring of Chief Medical Officer
28/01/2019
BURLINGAME, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Cancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
28/01/2019
RUTHERFORD, N.J., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomic medicine through molecular markers and diagnostics, today [...]
Nextech’s EDGE 2019 Creates Hub for Collaboration and Education for Medical Specialty Professionals
28/01/2019
The fifth annual user conference will offer insights into upcoming industry trends and provide education and networking opportunities for healthcare providers in all roles TAMPA, Fla., Jan. 28, 2019 (GLOBE NEWSWIRE) -- [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 décembre 2018
28/01/2019
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au En application de l'article L. 233-8 II du code de commerce et de l'article 222-12-5 du règlement général de l'AMF, les sociétés dont [...]
Indiana Biosciences Research Institute collaboration helps discover new genetic disease
28/01/2019
INDIANAPOLIS, Jan. 28, 2019 (GLOBE NEWSWIRE) -- A collaborative research project led in part by the Indiana Biosciences Research Institute (IBRI) has resulted in the first description of a new monogenic disease, named [...]
Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual Meeting
28/01/2019
AUSTIN, Texas, Jan. 28, 2019 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that Dr. Alice Gottlieb, M.D., Ph.D., will be giving the presentation “Bermekimab Shows Efficacy for Treating Hidradenitis [...]
North American Partners in Anesthesia (NAPA) quality data analysis suggests a surprising correlation between labor pain expectations in “millennial moms,” patient satisfaction and value-based payments
28/01/2019
A White Paper by Brent Lee, MD, MPH, Director of Clinical Excellence and Performance Improvement for North American Partners in Anesthesia (NAPA), describes the implications of a statistical study for hospital loyalty [...]
Ossur Hf : Transactions in relation to share buyback program
28/01/2019
Announcement no. 05/2019 28 January 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Vystar Debuts Enhanced RxAir® UV Light Air Purifiers to Fight Flu, Colds & Airborne Germs
28/01/2019
Features longer-lasting, more effective UV light for more efficient inactivation of viruses and bacteria RxAir available for medical, business and residential RxAir now available via Vystar’s medical distributors [...]
TOMI Environmental Solutions, Inc. Enters Into Exclusive Co-Marketing and Supply Agreement With Arkema Inc. to Develop the Market for Fogging Technology in Food Safety
28/01/2019
BEVERLY HILLS, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. ® (“TOMI”) (OTCQX: TOMZ) , a global company that specializes in disinfection and decontamination essentials using its premier [...]
Portola Pharmaceuticals Appoints Sheldon Koenig as Chief Commercial Officer
28/01/2019
Brings to Portola 30 Years’ Commercial Experience and Key Therapeutic Area Launch Expertise SOUTH SAN FRANCISCO, Calif., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA) today announced [...]
Protech Home Medical Announces Record 11X Adjusted EBITDA Growth and Significant Operating Cash Flow Growth in Year End Audited Financials
28/01/2019
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 28, 2019 (GLOBE NEWSWIRE) -- Protech Home [...]
Dr. Mitesh Borad Joins OncBioMune Scientific Advisory Board
28/01/2019
BATON ROUGE, La., Jan. 28, 2019 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a clinical-stage biopharmaceutical company engaged in the development of a proprietary [...]

Pages